176 related articles for article (PubMed ID: 32961484)
1. Dyregulation of the lncRNA TPT1-AS1 positively regulates QKI expression and predicts a poor prognosis for patients with breast cancer.
Hu C; Fang K; Zhang X; Guo Z; Li L
Pathol Res Pract; 2020 Nov; 216(11):153216. PubMed ID: 32961484
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA TPT1-AS1 sensitizes breast cancer cell to paclitaxel and inhibits cell proliferation by miR-3156-5p/caspase 2 axis.
Huang Y; Zheng Y; Shao X; Shi L; Li G; Huang P
Hum Cell; 2021 Jul; 34(4):1244-1254. PubMed ID: 33999360
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA TPT1-AS1 promotes cell growth and metastasis in cervical cancer via acting AS a sponge for miR-324-5p.
Jiang H; Huang G; Zhao N; Zhang T; Jiang M; He Y; Zhou X; Jiang X
J Exp Clin Cancer Res; 2018 Jul; 37(1):169. PubMed ID: 30045766
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA Down syndrome cell adhesion molecule-anti-sense 1 promotes gastric carcinoma cell proliferation and migration by regulating the miR-204/TPT1 axis.
Wang N; Yang Y; Jia GZ; Wang K; Zhou S; Zhang B; Zhang ZS; Qiao Q; He XL
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S187-S195. PubMed ID: 34372727
[No Abstract] [Full Text] [Related]
5. Guizhi Fuling pills inhibit the proliferation, migration and invasion of human cutaneous malignant melanoma cells by regulating the molecular axis of LncRNA TPT1-AS1 / miR-671-5p.
Zhang B
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):148-154. PubMed ID: 33040829
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
Tang J; Huang F; Wang H; Cheng F; Pi Y; Zhao J; Li Z
Bosn J Basic Med Sci; 2021 Feb; 21(1):39-46. PubMed ID: 32156253
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X
Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821
[TBL] [Abstract][Full Text] [Related]
8. [Effects of tumor protein translation control antisense RNA1 on radiosensitivity, proliferation, migration and invasion of hepatocellular carcinoma cells by targeting miR-30c-5p].
Zhai JJ; Du XR; Li CX
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1054-1061. PubMed ID: 34695895
[No Abstract] [Full Text] [Related]
9. Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation.
Jia L; Song Y; Mu L; Li Q; Tang J; Yang Z; Meng W
J Cell Physiol; 2020 Apr; 235(4):3679-3689. PubMed ID: 31637705
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
Yang J; Wu W; Wu M; Ding J
In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
[TBL] [Abstract][Full Text] [Related]
11. Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells.
Jin Y; Xu L; Zhao B; Bao W; Ye Y; Tong Y; Sun Q; Liu J
Cell Cycle; 2022 May; 21(9):908-920. PubMed ID: 35112997
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.
Zhao P; Guan H; Dai Z; Ma Y; Zhao Y; Liu D
Eur J Pharmacol; 2019 Dec; 865():172778. PubMed ID: 31705901
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA TPT1-AS1 promotes the progression and metastasis of colorectal cancer by upregulating the TPT1-mediated FAK and JAK-STAT3 signalling pathways.
Zhang L; Ye F; Zuo Z; Cao D; Peng Y; Li Z; Huang J; Duan L
Aging (Albany NY); 2021 Jan; 13(3):3779-3797. PubMed ID: 33428595
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of IncRNA TPT1-AS1 Suppresses Hepatocellular Carcinoma Cell Proliferation by Downregulating CDK2.
Wei W; Huang X; Shen X; Lian J; Chen Y; Wang W; Huang J; Zhang B
Crit Rev Eukaryot Gene Expr; 2022; 32(1):1-9. PubMed ID: 35377976
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
16. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
[No Abstract] [Full Text] [Related]
17. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
Fu A; Yu Z; Zhang E; Song J
Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
[TBL] [Abstract][Full Text] [Related]
19. LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6.
Zhang X; Zhao X; Chang L; Liu F; Li C; Ge P
Breast Cancer; 2022 Sep; 29(5):908-920. PubMed ID: 35678943
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA TTC39A-AS1 Promotes Breast Cancer Tumorigenicity by Sponging MicroRNA-483-3p and Thereby Upregulating MTA2.
Zhou Z; Yang P; Zhang B; Yao M; Jia Y; Li N; Liu H; Bai H; Gong X
Pharmacology; 2021; 106(11-12):573-587. PubMed ID: 34488224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
